arrow
S

Santhanam Sundar

nottingham university hospital nhs trust
H指数:32
被引数:7,101

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study

更正:细胞减灭术后辅助化疗开始时间与上皮性卵巢癌患者生存结局的关系:一项回顾性队列研究

2026-09-030
OA
UK real-world data of radium-223 dichloride in metastatic prostate cancer

英国镭-223二氯化物在转移性前列腺癌中的真实世界数据

2025-12-010
PRE
The Real-World Impact of PARP Inhibitor Maintenance Therapy in High Grade Serous Tubo-Ovarian and Peritoneal Cancers

PARP抑制剂维持治疗在高分级浆液性输卵管-卵巢及腹膜癌中的真实世界影响

2025-11-060
OAAI
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

二甲双胍用于开始接受雄激素剥夺治疗的转移性前列腺癌患者:一项STAMPEDE平台方案的随机III期试验

2025-07-070
OAAI
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial

多西他赛治疗非转移性前列腺癌: STAMPEDE随机对照试验的长期生存结果

2022-07-2514
OAAI
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
2020-12-01118
OAAI